Clara Foods
-
DATABASE (25)
-
ARTICLES (67)
Foods for Tomorrow / Heura Foods
Sold at 2,000+ outlets in four continents, the Heura brand comprises sustainably produced, nutritious, plant-based vegan products that mimic both chicken and beef.
Sold at 2,000+ outlets in four continents, the Heura brand comprises sustainably produced, nutritious, plant-based vegan products that mimic both chicken and beef.
Horizons Ventures is a Hong Kong-based venture capital firm that manages the personal investments of Li Ka-shing, one of Hong Kong’s richest businessmen. Horizons’ investments cover a wide range of tech, media, and telecommunications companies. Standouts include artificial intelligence company DeepMind (acquired by Google in 2014), plant-based meat replacement makers Impossible Foods, and video conferencing software Zoom. It has also backed consumer-facing businesses like Atomo Coffee in Australia, Kopi Kenangan in Indonesia, and US-based distilled spirits company Endless West.
Horizons Ventures is a Hong Kong-based venture capital firm that manages the personal investments of Li Ka-shing, one of Hong Kong’s richest businessmen. Horizons’ investments cover a wide range of tech, media, and telecommunications companies. Standouts include artificial intelligence company DeepMind (acquired by Google in 2014), plant-based meat replacement makers Impossible Foods, and video conferencing software Zoom. It has also backed consumer-facing businesses like Atomo Coffee in Australia, Kopi Kenangan in Indonesia, and US-based distilled spirits company Endless West.
Serena Ventures is a venture capital investment firm founded by professional tennis player and businesswoman Serena Williams. The company focuses on early-stage companies founded by young, diverse teams. Since it was founded in 2014, it has invested in more than 30 companies with a cumulative market cap of $12b. Coffee brand Kopi Kenangan is its first investment in the Indonesian market. Serena Ventures has invested in notable companies like plant-based meat maker Impossible Foods, cryptocurrency exchange Coinbase, as well as Serena Williams’ own fashion label, S by Serena.
Serena Ventures is a venture capital investment firm founded by professional tennis player and businesswoman Serena Williams. The company focuses on early-stage companies founded by young, diverse teams. Since it was founded in 2014, it has invested in more than 30 companies with a cumulative market cap of $12b. Coffee brand Kopi Kenangan is its first investment in the Indonesian market. Serena Ventures has invested in notable companies like plant-based meat maker Impossible Foods, cryptocurrency exchange Coinbase, as well as Serena Williams’ own fashion label, S by Serena.
Formerly known as Google Ventures, GV is the investment arm of Alphabet Inc. Although Alphabet is its sole limited partner, the VC operates independently from Google. It invests in seed, venture and growth-stage funding rounds with more than 300 companies in its portfolio worth over $5bn. Headquartered in California’s Mountain View, GV has offices in San Francisco, Boston, New York and London. The VC has been actively involved in Silicon Valley’s investment rounds for prominent startups like Uber, Slack, Ripple, Impossible Foods, Lime and Medium.
Formerly known as Google Ventures, GV is the investment arm of Alphabet Inc. Although Alphabet is its sole limited partner, the VC operates independently from Google. It invests in seed, venture and growth-stage funding rounds with more than 300 companies in its portfolio worth over $5bn. Headquartered in California’s Mountain View, GV has offices in San Francisco, Boston, New York and London. The VC has been actively involved in Silicon Valley’s investment rounds for prominent startups like Uber, Slack, Ripple, Impossible Foods, Lime and Medium.
Founded in 2012, Purple Orange’s objective is to support the transition away from animals in the food chain, supporting early-stage food and biotech companies across the globe with a focus on alternative proteins and cellular agriculture. It currently has 12 startups from different nations in its portfolio. Its most recently disclosed investments have been in the December 2020 pre-seed round of Chinese cultured meat startup CellX and in the November 2020 $500,000 pre-seed round of Swedish plant-based food vending startup VEAT.
Founded in 2012, Purple Orange’s objective is to support the transition away from animals in the food chain, supporting early-stage food and biotech companies across the globe with a focus on alternative proteins and cellular agriculture. It currently has 12 startups from different nations in its portfolio. Its most recently disclosed investments have been in the December 2020 pre-seed round of Chinese cultured meat startup CellX and in the November 2020 $500,000 pre-seed round of Swedish plant-based food vending startup VEAT.
Ahmir Khalib Thompson, better known as Questlove, is an American DJ, songwriter and filmmaker. He is the drummer and joint frontman of the hip-hop band the Roots and has also made several appearances in movies and television. He has been also a musical director at the 2020 and 2021 Academy Awards ceremony. The plant-based food investor was reportedly behind President Barack Obama’s upcoming birthday celebration in 2021. Questlove has backed plant-based food companies Impossible Foods and NotCo.Also in 2021, Questlove directed a film about the 1969 Harlem Cultural Festival, the Summer of Soul (...Or, When the Revolution Could Not Be Televised), which won the US Grand Jury Prize and the Audience Award for documentary at the Sundance Film Festival.
Ahmir Khalib Thompson, better known as Questlove, is an American DJ, songwriter and filmmaker. He is the drummer and joint frontman of the hip-hop band the Roots and has also made several appearances in movies and television. He has been also a musical director at the 2020 and 2021 Academy Awards ceremony. The plant-based food investor was reportedly behind President Barack Obama’s upcoming birthday celebration in 2021. Questlove has backed plant-based food companies Impossible Foods and NotCo.Also in 2021, Questlove directed a film about the 1969 Harlem Cultural Festival, the Summer of Soul (...Or, When the Revolution Could Not Be Televised), which won the US Grand Jury Prize and the Audience Award for documentary at the Sundance Film Festival.
San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods.
San Francisco-based BOND is a spinoff of Kleiner Perkins and its original digital growth fund. BOND was launched in 2019, investing across market segments and geographies. To date, it has raised two funds totaling $3.3bn and currently has 32 portfolio companies. Its recent investments include Portuguese home physiotherapy tech SWORD, the world’s fastest-growing musculoskeletal solution, in June 2021 in a $85m Series C funding round; and co-leading the July 2021 $50m Series B round of US fungi-based alt-protein startup Meati Foods.
Founded in Amsterdam in 2011, Rockstart is a global accelerator-VC focusing on sustainability startups across market segments. Rockstart also runs specialist programs like agrifood in Copenhagen, healthcare in the Dutch town of Nijmegen and also in emerging tech in Bogota, Colombia. It specializes in developing business relationships for portfolio startups with global corporates such as Maersk, Shell and the Dutch Ministry of Health. Rockstart has invested in more than 250 startups, valued at €750m in total.Launched in 2019, Rockstart’s €22m agrifood fund secured investment partners including Vaekstfonden’s Green Future Fund and global dairy cooperative Arla Foods. It has invested in 20 food enterprises like Swiss zero-waste supermarket Lyfa and Danish alt-leather startup Beyond Leather Materials in 2021. Rockstart’s energy fund recently invested in the €730,000 pre-seed round of Danish carbon sequestration corporate marketplace, Klimate, in September 2021. Exits include Wercker, iClinic, Brincr and 3D Hubs.
Founded in Amsterdam in 2011, Rockstart is a global accelerator-VC focusing on sustainability startups across market segments. Rockstart also runs specialist programs like agrifood in Copenhagen, healthcare in the Dutch town of Nijmegen and also in emerging tech in Bogota, Colombia. It specializes in developing business relationships for portfolio startups with global corporates such as Maersk, Shell and the Dutch Ministry of Health. Rockstart has invested in more than 250 startups, valued at €750m in total.Launched in 2019, Rockstart’s €22m agrifood fund secured investment partners including Vaekstfonden’s Green Future Fund and global dairy cooperative Arla Foods. It has invested in 20 food enterprises like Swiss zero-waste supermarket Lyfa and Danish alt-leather startup Beyond Leather Materials in 2021. Rockstart’s energy fund recently invested in the €730,000 pre-seed round of Danish carbon sequestration corporate marketplace, Klimate, in September 2021. Exits include Wercker, iClinic, Brincr and 3D Hubs.
Advisor, board member, co-founder of NovoNutrients
Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO. Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications, developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley
Brian Sefton has been co-founder, a board member and a part-time advisor at NovoNutrients, a San Francisco-based biotech manufacturer of alt-protein produced from fermentation and CO2 since it was founded in 2017. In 2009, he co-founded research entity Oakbio, from which NovoNutrients evolved, and was its President and CTO. Sefton was CTO and President at NovoNutrients and also co-CEO and Chief Scientist at Oakbio until 2021 when he became the CEO at San Francisco-based fermentation commercialization startup Sincarne. Between 2005 and 2011, Sefton was also CEO at pharma research company Pharmadyn, working on drugs development for Alzheimer's Disease, and, for three of those years, was also Managing Partner of Stratsyn, a consultancy specializing in creation, development, management and fund raising for not-for-profit organizations. Sefton’s earlier posts include: directing nanotechnology commercialization and investment company Nanosig for three years, CEO of Silicon Valley’s Fastlane, a high-profile pioneer in real-time network traffic and security analysis for six years; and, simultaneously, being CEO at Bluebox Communications, developing high-end network security applications and appliances for Fortune 500 companies and the US government.Sefton holds an MBA from Santa Clara University in California and a bachelor’s degree in biochemistry from the University of California, Berkeley
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
- 1
- 2
New Food Invest: Challenges of growing an alt-protein startup
Founders of three alt-protein startups in the US share what motivated them to start, their personal experiences growing the businesses, getting funding and finding strategic partners
How influential is your influencer? This startup has the metrics to turn buzz into gold
Influencity is a new way for companies and brands to win in social media marketing
New Food Invest: Building a plant-based business in the US
With plant-based startups experiencing exponential growth but facing increasingly intense competition, experts consider the opportunities and barriers in the sector
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
Heura by Foods for Tomorrow: Another new kid on the multibillion-dollar alternative protein market
Already selling in nine countries, Heura’s recent entry into the UK, Europe's largest market for meat substitutes, could prove its biggest test to date
Dao Foods unfazed by China tech crackdown, says alternative proteins aligned with state goals
Impact investor Dao Foods expects government support for alternative proteins to come, as it announces second batch of startups, diversifying into fermentation and cell-based proteins
Cubiq Foods: Bioreactor farms producing the food of tomorrow
Growing appetite for meat alternatives expected to fuel demand for Cubiq’s low calorie, Omega 3-enriched lab-grown fats
Plant-based eggs (Part II): The foodtech startups to watch
Here’s a shortlist of the foodtech startups to watch in the global vegan egg market
Healthy eating: The Southeast Asian startups making it a breeze
From meal plans to novel ingredients, agriculture and foodtech startups in the region are developing new ways to improve nutrition without sacrificing taste
In Spain, women are busy launching startups
Official data show women-led startups are on the rise in Spain. We take you to some of the biggest names in the game
Future Food Asia 2021: Consumers crucial for agrifood growth
President of AppHarvest David Lee thinks consumers must be told the truth about the need for technology for change in food because capitalism and consumerism are powerful forces
Future Food Asia 2021 announces finalists for $100,000 prize
Ten startups from agrifood tech and cleantech sectors will pitch during the five-day conference, are also eligible for two more prizes from sponsors Cargill and Thai Wah
Ento: Making cookies and burger patties from crickets
From whole-roasted crickets and granola bars to sausages and meatballs, Ento aims to tap the growing market for insect-based alternative proteins, targeting enthusiasts and early adopters
Do plant-based meat alternatives stand a chance in China, the world's largest meat consumer?
Major food brands and foodtech startups are trying to build their following in a nascent market forecast to grow to nearly $12bn worth by 2023
AquaCultured Foods: World's first whole-cut vegan seafood made through microbial fermentation
Armed with its fermentation technology and proprietary strain of fungi, AquaCultured is closing an oversubscribed funding round, raising more than $1.5m to launch its non-GMO seafood alternatives, with plans to expand to more food verticals and overseas
Sorry, we couldn’t find any matches for“Clara Foods”.
POPULAR DATABASE
